CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Media Room

Explore our latest press releases, announcements, and updates on groundbreaking immunotherapy research.

For media inquiries, please contact us at [email protected].

  • Media Room Article

    FDA Approves New Immunotherapy for Metastatic Melanoma

    FDA announced today its approval of a new immunotherapy for advanced melanoma, the deadliest and most difficult-to-treat…

    March 25, 2011
  • Media Room Article

    New Perspectives on Cancer and the Immune System

    In a new article published in Science, three CRI scientists describe how advances in the field of…

    March 25, 2011
  • Media Room Article

    Cancer Research Institute Announces Second Investment from Its Cancer Vaccine Acceleration Fund to Enable Manufacture of Powerful Immune Stimulant

    CRI's Cancer Vaccine Acceleration Fund (CVAF) has completed a new investment agreement with biotech Oncovir to enable…

    January 21, 2011
  • Media Room Article

    Cancer Research Institute Announces Launch of Cancer Vaccine Acceleration Fund

    New model of venture philanthropy aims to improve cancer patient care sooner by speeding development of highly…

    December 14, 2010
  • Media Room Article

    Improving Endpoints for Cancer Immunotherapy Clinical Trials

    The Cancer Research Institute Cancer Immunotherapy Consortium, the leading global initiative in advancing the emerging field of…

    September 23, 2010
  • Media Room Article

    2010 William B. Coley Award Winners to be Honored at CRI’s 24th Annual Awards Dinner in NYC

    CRI announced today the three winners of the 2010 William B. Coley Award for Distinguished Research in…

    June 7, 2010
  • Media Room Article

    New Cancer Immunotherapy Helps Patients with Metastatic Melanoma Live Longer

    A significant new immunotherapy, created by CRI Scientific Advisory Council Associate Director James P. Allison, Ph.D, is…

    June 7, 2010
  • Media Room Article

    First FDA Approval of Therapeutic Cancer Vaccine a Milestone Victory for Cancer Immunotherapy

    CRI celebrates yesterday’s announcement of the first therapeutic cancer vaccine to receive approval from the U.S. Food…

    April 30, 2010
  • Media Room Article

    Scientists Develop Novel Technology to Assess Cancer Vaccine-Induced CD4+ T-cell Response

    A team of tumor immunologists in France and Switzerland has established an improved, reliable immune monitoring tool…

    April 7, 2010
Previous Page
1 … 17 18 19 20 21
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give
CRI Logo

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute